** Sign up for our free **email newsletter**.
**A Metabolic Weakness in Cancer Stem Cells** Stem cells are central to both normal blood production and blood cancers.
Researchers now plan to investigate drugs that target NAMPT in clinical studies involving people with MDS and related blood cancers.
A clinical trial tested whether boosting NAD+ using nicotinamide riboside could help.
Financial support for ScienceDaily comes from advertisements and referral programs.